How to buy IDEXX Laboratories shares

IDEXX Laboratories shares have increased 2.98% from their previous closing price ($554.77). Learn how to easily invest in IDEXX Laboratories shares in the UK.

IDEXX Laboratories Inc (IDXX) is a publicly traded diagnostics and research business based in the US which employs around 11,000 staff. IDEXX Laboratories is listed on the NASDAQ and traded in US dollars. Its current price of $571.31 is 7.5% up on its price a month ago ($531.52).

How to buy shares in IDEXX Laboratories

  1. Choose a platform. If you're a beginner, our share trading platform picks below can help you choose.
  2. Open your account. Provide your personal information and sign up.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: IDXX in this case.
  5. Research shares. The platform should provide the latest information available.
  6. Buy your shares. Place a market order or limit order with your preferred number of shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Our top picks for where to buy IDEXX Laboratories shares

Best for 0% commission stocks

Finder Award
Capital at risk. Other fees apply.
Copy picks from top traders
  • Commission-free stock trades
  • Receive dividend payments
  • Invest in fractional shares

Best for beginner investments

Capital at risk. T&Cs apply.
Discounts for regular investing
  • 13,000+ shares to invest in
  • Choose from over 5,000 ETFs
  • Exclusive out-of-hours trading

Best for US shares

Finder Award
Capital at risk. T&Cs apply.
Try Plus free for 3 months
  • 0% commission on trades
  • Choose from 3000+ stocks
  • Real-time live pricing

Fees calculator for buying IDEXX Laboratories shares with popular apps

Both exchange rates and share prices fluctuate in real time, so the costs estimated here should be considered as a guide only. They don't factor in spreads, which can be hard to pin down. Always refer to the platform itself for availability and pricing.

Quantity of shares

1
Platform Finder score Account fee Min. initial deposit Trade cost Link
eToro Free Stocks logo
4.39/5 ★★★★★
£0 $50 £453.30
Go to siteCapital at risk
IG Share Dealing logo
4.07/5 ★★★★★
£0 £0 £463.30
Go to siteCapital at risk
XTB logo
4.3/5 ★★★★★
£0 £0 £453.30
Go to siteCapital at risk
CMC Invest share dealing account logo
4.38/5 ★★★★★
£0 £0 £453.30
Go to siteCapital at risk
Hargreaves Lansdown Fund and Share Account logo
4.2/5 ★★★★★
£0 £1 £467.51
Go to siteCapital at risk

Full comparison of share dealing platforms

These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Alternative ways to invest in IDEXX Laboratories

Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including IDEXX Laboratories), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.

IDEXX Laboratories is a major part of the NASDAQ, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).

IconFund5-year performanceLink to invest
Invesco iconInvesco S&P 500 (SPXP)70.17%Invest with IGCapital at risk
DWS Xtrackers iconXtrackers S&P 500 Swap (XSPX)69.98%Invest with IGCapital at risk
HSBC iconHSBC S&P 500 (HSPX)68.59%Invest with IGCapital at risk
Vanguard iconVanguard S&P 500 (VUSA)68.24%Capital at risk
iShares iconiShares Core S&P 500 (CSP1)68.20%Invest with eToroCapital at risk
SPDR iconSPDR S&P 500 ETF (SPX5)67.96%Invest with IGCapital at risk

Is it a good time to buy IDEXX Laboratories stock?

Only you can make the decision on the time to leap... but here's some supporting information and analysis.

Use our graph to track the performance of IDXX stocks over time.

Share price volatility

Over the last 12 months, IDEXX Laboratories's shares have ranged in value from as little as $372.5 up to $579.68. A popular way to gauge a stock's volatility is its "beta".

IDXX.US volatility(beta: 1.25)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IDEXX Laboratories's is 1.253. This would suggest that IDEXX Laboratories's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Historical closes compared with the last close of $571.31

1 week (2024-02-15)2.84%
1 month (2024-01-22)7.49%
3 months (2023-11-21)19.44%
6 months (2023-08-22)13.57%
1 year (2023-02-21)19.95%
2 years (2022-02-22)20.36%
3 years (2021-02-22)8.78%
5 years (2019-02-21)173.12%

The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Promoted
eToro Free Stocks
Invest in IDEXX Laboratories shares
Finder Award
  • Start investing from $50
  • Pay no stamp duty on UK shares
  • Commission-free trading. Other fees may apply.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is IDEXX Laboratories under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the IDEXX Laboratories P/E ratio, PEG ratio and EBITDA

IDEXX Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 55x. In other words, IDEXX Laboratories shares trade at around 55x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of November 09, 2023 (20.44). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

However, IDEXX Laboratories's P/E ratio is best considered in relation to those of others within the industry or those of similar companies.

IDEXX Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.2985. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into IDEXX Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

However, it's sensible to consider IDEXX Laboratories's PEG ratio in relation to those of similar companies.

IDEXX Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $1.2 billion (£0.0 million).

The EBITDA is a measure of a IDEXX Laboratories's overall financial performance and is widely used to measure a its profitability.

To put that into context you can compare it against similar companies.

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

Go to site